E-cadherin, which was commonly thought to be inversely correlated with N-cadherin and deficient in tumor cells [24], was unexpectedly down-regulated in spite of the downregulation of N-cadherin and Vimentin. The gene discussed is CDH2; the disease is neoplasm.